M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study
Author:
Affiliation:
1. Momenta Pharmaceuticals, Inc. Cambridge Massachusetts USA
2. PRA Health Sciences Groningen The Netherlands
3. Drug Development Consulting North New Portland Maine USA
Funder
Momenta Pharmaceuticals, Inc
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1276
Reference39 articles.
1. Autoantibodies in Autoimmune Diseases
2. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
3. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?
4. The unmet need in rheumatology: Reports from the targeted therapies meeting 2017
5. Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study;Frontiers in Neuroscience;2024-02-01
2. Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab;Annals of Hematology;2024-02-01
3. Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis;Neurology;2024-01-23
4. Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease;Transfusion Medicine Reviews;2024-01
5. Exploiting the neonatal crystallizable fragment receptor to treat kidney disease;Kidney International;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3